Buhtoiarov et al. has shown that anti-CD40 antibody in combination with CpG-containing oligodeoxynucleotides (CpG), a toll-like receptor 9 agonist led to activation of tumoristatic macrophages and promoted anti-tumor immunity in NXS2 mouse model of neuroblastoma model (158). This evidence concerns the gene CD40 and neoplasm.